Safety Data SheetChemical Risk Assessment

Lanoxin Injection

by GlaxoSmithKline

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Lanoxin Injection is supplied by GlaxoSmithKline under product code LANOXIN INJECTION 250MCG/ML, LANOXIN INJECTION 500MCG/2ML, LANOXIN AMPOLLA, LANOXIN I.V SOLUCAO INJECTAVEL, LANOXIN INIETTABILE, LANOXIN INJECTIEVLOEISTOF, LANOXIN INJEKSJONSVAESKE, LANOXIN INYECTABLE, LANOXIN SOLUTION BUVABLE, NDC NO 0173-0260-10, NDC NO 0173-0260-35, DIGOXIN, FORMULATED PRODUCT. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under CHIP, 67/548/EEC regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 15 October 2004. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.


Language
English
Regulation
CHIP, 67/548/EEC
Revision Date
15 Oct 2004
Signal Word
Product Code
LANOXIN INJECTION 250MCG/ML, LANOXIN INJECTION 500MCG/2ML, LANOXIN AMPOLLA, LANOXIN I.V SOLUCAO INJECTAVEL, LANOXIN INIETTABILE, LANOXIN INJECTIEVLOEISTOF, LANOXIN INJEKSJONSVAESKE, LANOXIN INYECTABLE, LANOXIN SOLUTION BUVABLE, NDC NO 0173-0260-10, NDC NO 0173-0260-35, DIGOXIN, FORMULATED PRODUCT
CAS Number
20830-75-5,64-17-5

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a GlanceFrom the Safety Data Sheet
Signal Word: -

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.


Common QuestionsAbout this Safety Data Sheet

Need help with Safety Data Sheets? You've come to the right place!

CONTACT US